Search Results 971-980 of 17830 for corticosteroid

1. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   corticosteroids is acceptable. - Has a known additional malignancy ... corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not

2. A Study of a Personalized Neoantigen Cancer Vaccine - Mayo Clinic

   Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not ...

3. INCB161734 for Advanced or Metastatic Solid Tumors With KRAS G12D Mutation - Mayo Clinic

   Participants with asthma that requires intermittent use of bronchodilators, inhaled corticosteroids, or local corticosteroid injections may participate; ...

4. Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) - Mayo Clinic

   History of intravitreal corticosteroid within 4 months of randomization. ... History of peribulbar or retrobulbar corticosteroid use for any reason within 2 ...

5. Transforaminal Lumbar Interbody Fusion (TLIF) - Mayo Clinic

   9 Has undergone administration of any type of corticosteroid, antineoplastic, immunostimulating, or immunosuppressive agents, or medications known to ...

6. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   ... corticosteroid therapy for ≥ 3 weeks. NOTE: carcinomatous meningitis is excluded regardless of clinical stability. Active autoimmune disease requiring ...

7. A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   parenteral corticosteroids;; total parenteral nutrition therapy; antibiotics for the treatment of CD; immunomodulatory agents; immunomodulatory biologic agents ...

8. Systemic mastocytosis - Diagnosis and treatment - Mayo Clinic

   Counteract the effects of the substances released by your mast cells, for example with corticosteroids; Inhibit the KIT gene to reduce the production of mast ...

9. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   Concomitant high dose corticosteroids other than what is part of treatment protocol (concurrent use of corticosteroids). EXCEPTION: Patients may be on ...

10. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

    Unchanged dose of immunosuppressive medications other than oral corticosteroids for ≥ 8 weeks before Screening. Willing to not start or stop any ...